SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

HC Wainwright Initiates Agios Coverage at Buy, Sets $55 Target

HC Wainwright initiated coverage of Agios Pharmaceuticals at Buy with a $55 price target. The target implies 44.3% upside from the Oct. 28 close of $38.12.

AGIO

Related stories